3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Oxaliplatin
1413
Fluorouracil
1301
Capecitabine
1088
Gemcitabine
1046
Leucovorin
932
Irinotecan
818
Bevacizumab
804
Cisplatin
671
Radiotherapy
536
Cetuximab
470
pembrolizumab
430
Paclitaxel
390
Nivolumab
337
130-nm albumin-bound paclitaxel
325
Drug Therapy
314
Docetaxel
287
S 1 (combination)
275
Sorafenib
266
Folfox protocol
261
Albumin-Bound Paclitaxel
259
sintilimab
211
durvalumab
210
Surgical Procedures, Operative
204
tislelizumab
203
Radiosurgery
202
lenvatinib
201
apatinib
200
Carboplatin
188
Magnetic Resonance Spectroscopy
183
regorafenib
181
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Glutamyl Aminopeptidase
×
Gastrointestinal
×
Clear all
NCT05441163
2025-06-24
ProActIF-01
Institut Curie
Phase NA
Recruiting
50 enrolled